AstraZeneca Halts £200 Million Investment in Cambridge Research Site
London: AstraZeneca, the largest company in Britain, has paused its planned £200 million (USD 271.26 million) investment in its Cambridge research site, a spokesperson announced on Friday. This decision reflects a growing trend among drug makers recon…